Research graph
References from The probiotic Lacticaseibacillus rhamnosus SD11 alleviates the progression of liver and colon damage through modulation of inflammation and tight junction proteins in streptozotocin-induced diabetic mice. Local targets link to admitted publications; unresolved targets remain external evidence.
Erratum: Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology.
10.3389/fendo.2023.1172597 · 2023 · External reference
Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes
10.1016/j.ejim.2022.03.025 · 2022 · External reference
Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver Disease
10.1002/hep.31014 · 2020 · External reference
A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier.
10.1007/s00394-020-02431-w · 2021 · External reference
Effect of probiotics on glycemic control: a systematic review and meta-analysis of randomized, controlled trials.
10.1371/journal.pone.0132121 · 2015 · External reference
Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
10.1126/science.aar3318 · 2018 · External reference
Lactobacillus species and genotypes associated with dental caries in Thai preschool children.
10.1111/j.2041-1014.2009.00556.x · 2010 · External reference
Inhibitory effect of oral Lactobacillus against oral pathogens
10.1111/j.1472-765x.2011.03132.x · 2011 · External reference
Effect of long-term consumption of Lactobacillus paracasei SD1 on reducing mutans streptococci and caries risk: a randomized placebo-controlled trial.
10.3390/dj3020043 · 2015 · External reference
Effect of fermented milk containing Lactobacillus rhamnosus SD11 on oral microbiota of healthy volunteers: A randomized clinical trial
10.3168/jds.2017-12961 · 2017 · External reference
Fermented milk containing a potential probiotic Lactobacillus rhamnosus SD11 with maltitol reduces Streptococcus mutans: A double-blind, randomized, controlled study.
10.1016/j.jds.2020.03.003 · 2020 · External reference
Short-term use of Lacticaseibacillus rhamnosus SD11 and the oral microbiome: Low caries RCT study
2023 · External reference
Effects of potential probiotics on the expression of cytokines and human beta-defensins in human gingival epithelial cells and in vivo efficacy in a dog model
10.1016/j.archoralbio.2022.105513 · 2022 · External reference
Probiotics of Lacticaseibacillus paracasei SD1 and Lacticaseibacillus rhamnosus SD11 attenuate inflammation and beta-cell death in streptozotocin-induced type 1 diabetic mice.
10.1371/journal.pone.0284303 · 2023 · External reference
Lactobacillus amylovorus promotes lactose utilization in small intestine and enhances intestinal barrier function in intrauterine growth restricted piglets
10.1016/j.tjnut.2023.12.004 · 2024 · External reference
Contribution of Lactobacilli on intestinal mucosal barrier and diseases: perspectives and challenges of Lactobacillus casei.
2022 · External reference
Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
10.3350/cmh.2020.0125 · 2021 · External reference
Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice.
10.1039/c9fo01062a · 2019 · External reference
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
10.1371/journal.pbio.3000410 · 2020 · External reference
Ethanolic extracts of Pluchea indica (L.) leaf pretreatment attenuates cytokine-induced beta-cell apoptosis in multiple low-dose streptozotocin-induced diabetic mice
10.1371/journal.pone.0212133 · 2019 · External reference
Treatment with Pluchea indica (L.) Less. leaf ethanol extract alleviates liver injury in multiple low-dose streptozotocin-induced diabetic BALB/c mice
2020 · External reference
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions
10.1111/j.1572-0241.1999.01377.x · 1999 · External reference
Nonalcoholic fatty liver disease: Definitions, risk factors, and workup.
10.1002/cld.81 · 2012 · External reference
Hyperglycemia aggravates acute liver injury by promoting liver-resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR-mediated autophagy induction
10.1111/imcb.12297 · 2020 · External reference
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
10.1038/cmi.2015.104 · 2016 · External reference
The role for gut permeability in the pathogenesis of type 1 diabetes-a solid or leaky concept?
10.1111/pedi.12305 · 2015 · External reference
Lactobacillus gasseri CKCC1913 mediated modulation of the gut-liver axis alleviated insulin resistance and liver damage induced by type 2 diabetes.
10.1039/d3fo01701j · 2023 · External reference
Evaluation of anti-diabetic attributes of Lactobacillus rhamnosus MTCC: 5957, Lactobacillus rhamnosus MTCC: 5897 and Lactobacillus fermentum MTCC: 5898 in streptozotocin induced diabetic rats
10.1016/j.micpath.2018.10.015 · 2018 · External reference
Regulation of postabsorptive and postprandial glucose metabolism by insulin-dependent and insulin-independent mechanisms: an integrative approach.
10.3390/nu13010159 · 2021 · External reference
Diabetic‑induced alterations in hepatic glucose and lipid metabolism: The role of type 1 and type 2 diabetes mellitus (Review).
10.3892/mmr.2020.11175 · 2020 · External reference
Prebiotics and probiotics: therapeutic tools for nonalcoholic fatty liver disease.
10.3390/ijms241914918 · 2023 · External reference
Mechanisms of macrophage polarization in insulin signaling and sensitivity.
10.3389/fendo.2020.00062 · 2020 · External reference
Expression of intestinal tight junction proteins in patients with non-alcoholic fatty liver disease
2014 · External reference
